Neurobo Pharmaceuticals Inc (NRBO) stock is lower by -96.92% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives NRBO stock a score of 7 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 1. NRBO's rank also includes a long-term technical score of 20.
NRBO has an Overall Score of 7. Find out what this means to you and get the rest of the rankings on NRBO!
Neurobo Pharmaceuticals Inc (NRBO) stock has fallen -5.69% while the S&P 500 is lower by -0.07% as of 9:58 AM on Wednesday, Nov 30. NRBO is lower by -$0.09 from the previous closing price of $1.58 on volume of 205,875 shares. Over the past year the S&P 500 is lower by -13.40% while NRBO is lower by -96.92%. NRBO lost -$15.64 per share in the over the last 12 months.
Click Here to get the full Stock Report for Neurobo Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
